{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:31:49Z","timestamp":1787164309830,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["522001003"],"award-info":[{"award-number":["522001003"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","award":["not applicable"],"award-info":[{"award-number":["not applicable"]}],"id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3949-8","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T12:05:04Z","timestamp":1555329904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect)"],"prefix":"10.1186","volume":"19","author":[{"given":"Hedwig D.","family":"Vrijmoeth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6968-5165","authenticated-orcid":false,"given":"Jeanine","family":"Ursinus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margriet G.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tizza P.","family":"Zomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie A.","family":"Gauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna D.","family":"Tulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein","family":"Sprong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Knoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande M.","family":"Vermeeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barend","family":"van Kooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A. B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart-Jan","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joppe W. R.","family":"Hovius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees C.","family":"van den Wijngaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"issue":"1","key":"3949_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ttbdis.2014.09.006","volume":"6","author":"A Hofhuis","year":"2015","unstructured":"Hofhuis A, Harms M, van den Wijngaard C, Sprong H, van Pelt W. Continuing increase of tick bites and Lyme disease between 1994 and 2009. Ticks and tick-borne diseases. 2015;6(1):69\u201374.","journal-title":"Ticks and tick-borne diseases"},{"key":"3949_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13071-015-0777-6","volume":"8","author":"A Hofhuis","year":"2015","unstructured":"Hofhuis A, Harms M, Bennema S, van den Wijngaard CC, van Pelt W. Physician reported incidence of early and late Lyme borreliosis. Parasit Vectors. 2015;8:161.","journal-title":"Parasit Vectors"},{"key":"3949_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12889-016-3105-y","volume":"16","author":"A Hofhuis","year":"2016","unstructured":"Hofhuis A, Bennema S, Harms M, van Vliet AJ, Takken W, van den Wijngaard CC, et al. Decrease in tick bite consultations and stabilization of early Lyme borreliosis in the Netherlands in 2014 after 15 years of continuous increase. BMC Public Health. 2016;16:425.","journal-title":"BMC Public Health"},{"issue":"1","key":"3949_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","volume":"17","author":"G Stanek","year":"2011","unstructured":"Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2011;17(1):69\u201379.","journal-title":"Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"1","key":"3949_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.amjmed.2009.05.011","volume":"123","author":"D Cerar","year":"2010","unstructured":"Cerar D, Cerar T, Ruzic-Sabljic E, Wormser GP, Strle F. Subjective symptoms after treatment of early Lyme disease. Am J Med. 2010;123(1):79\u201386.","journal-title":"Am J Med"},{"issue":"5","key":"3949_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1600-0404.2010.01482.x","volume":"124","author":"R Eikeland","year":"2011","unstructured":"Eikeland R, Mygland A, Herlofson K, Ljostad U. European neuroborreliosis: quality of life 30 months after treatment. Acta Neurol Scand. 2011;124(5):349\u201354.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"3949_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0002-9343(03)00308-5","volume":"115","author":"J Nowakowski","year":"2003","unstructured":"Nowakowski J, Nadelman RB, Sell R, McKenna D, Cavaliere LF, Holmgren D, et al. Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med. 2003;115(2):91\u20136.","journal-title":"Am J Med"},{"issue":"9","key":"3949_CR8","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/cid\/cix568","volume":"65","author":"FC Knudtzen","year":"2017","unstructured":"Knudtzen FC, Andersen NS, Jensen TG, Skarphedinsson S. Characteristics and clinical outcome of Lyme Neuroborreliosis in a high endemic area, 1995-2014: a retrospective cohort study in Denmark. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017;65(9):1489\u201395.","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America."},{"issue":"6","key":"3949_CR9","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.1016\/j.ijid.2013.01.008","volume":"17","author":"JN Aucott","year":"2013","unstructured":"Aucott JN, Crowder LA, Kortte KB. Development of a foundation for a case definition of post-treatment Lyme disease syndrome. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2013;17(6):e443\u20139.","journal-title":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases"},{"issue":"2","key":"3949_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/arclin\/acw098","volume":"32","author":"KT Bechtold","year":"2017","unstructured":"Bechtold KT, Rebman AW, Crowder LA, Johnson-Greene D, Aucott JN. Standardized symptom measurement of individuals with early Lyme disease over time. Arch Clin Neuropsychol. 2017;32(2):129\u201341.","journal-title":"Arch Clin Neuropsychol"},{"issue":"1","key":"3949_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/02813432.2017.1288812","volume":"35","author":"KE Eliassen","year":"2017","unstructured":"Eliassen KE, Hjetland R, Reiso H, Lindbaek M, Tschudi-Madsen H. Symptom load and general function among patients with erythema migrans: a prospective study with a 1-year follow-up after antibiotic treatment in Norwegian general practice. Scand J Prim Health Care. 2017;35(1):75\u201383.","journal-title":"Scand J Prim Health Care"},{"issue":"5","key":"3949_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/jama.283.5.609","volume":"283","author":"EG Seltzer","year":"2000","unstructured":"Seltzer EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED. Long-term outcomes of persons with Lyme disease. JAMA. 2000;283(5):609\u201316.","journal-title":"JAMA."},{"key":"3949_CR13","doi-asserted-by":"crossref","unstructured":"Weitzner E, McKenna D, Nowakowski J, Scavarda C, Dornbush R, Bittker S, et al. Long-term assessment of post-treatment symptoms in patients with culture-confirmed early Lyme disease. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015.","DOI":"10.1093\/cid\/civ735"},{"issue":"1","key":"3949_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1468-1331.2009.02756.x","volume":"17","author":"U Ljostad","year":"2010","unstructured":"Ljostad U, Mygland A. Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors. Eur J Neurol. 2010;17(1):118\u201323.","journal-title":"Eur J Neurol"},{"issue":"3","key":"3949_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018220","volume":"6","author":"J Sjowall","year":"2011","unstructured":"Sjowall J, Fryland L, Nordberg M, Sjogren F, Garpmo U, Jansson C, et al. Decreased Th1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans. PLoS One. 2011;6(3):e18220.","journal-title":"PLoS One"},{"issue":"2","key":"3949_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.amjmed.2014.09.022","volume":"128","author":"GP Wormser","year":"2015","unstructured":"Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Nowakowski J. Long-term assessment of fatigue in patients with culture-confirmed Lyme disease. Am J Med. 2015;128(2):181\u20134.","journal-title":"Am J Med"},{"key":"3949_CR17","doi-asserted-by":"crossref","unstructured":"Dersch R, Sommer H, Rauer S, Meerpohl JJ. Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review. J Neurol. 2015.","DOI":"10.1007\/s00415-015-7923-0"},{"issue":"6","key":"3949_CR18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/eurpub\/ckv091","volume":"25","author":"CC Wijngaard van den","year":"2015","unstructured":"van den Wijngaard CC, Hofhuis A, Harms MG, Haagsma JA, Wong A, de Wit GA, et al. The burden of Lyme borreliosis expressed in disability-adjusted life years. Eur J Pub Health. 2015;25(6):1071\u20138.","journal-title":"Eur J Pub Health"},{"issue":"9","key":"3949_CR19","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"G Wormser","year":"2006","unstructured":"Wormser G, Dattwyler R, Shapiro E, Halperin J, Steere A, Klempner M, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089\u2013134.","journal-title":"Clin Infect Dis"},{"key":"3949_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jpsychores.2017.05.007","volume":"98","author":"M Worm-Smeitink","year":"2017","unstructured":"Worm-Smeitink M, Gielissen M, Bloot L, van Laarhoven HWM, van Engelen BGM, van Riel P, et al. The assessment of fatigue: psychometric qualities and norms for the checklist individual strength. J Psychosom Res. 2017;98:40\u20136.","journal-title":"J Psychosom Res"},{"issue":"11","key":"3949_CR21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0895-4356(98)00097-3","volume":"51","author":"N Aaronson","year":"1998","unstructured":"Aaronson N, Muller M, Cohen P, Essink-Bot M, Fekkes M, Sanderman R, et al. Translation, validation, and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol. 1998;51(11):1055\u201368.","journal-title":"J Clin Epidemiol"},{"key":"3949_CR22","first-page":"37","volume":"2","author":"R Ponds","year":"2006","unstructured":"Ponds R, Van Boxtel M, Jolles J. De Cognitive Failure Questionnaire als maat voor subjectief cognitief functioneren. Tijdschrift voor Neuropsychologie. 2006;2:37\u201345.","journal-title":"Tijdschrift voor Neuropsychologie"},{"issue":"1","key":"3949_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00127-010-0317-9","volume":"47","author":"BT Stegenga","year":"2012","unstructured":"Stegenga BT, Kamphuis MH, King M, Nazareth I, Geerlings MI. The natural course and outcome of major depressive disorder in primary care: the PREDICT-NL study. Soc Psychiatry Psychiatr Epidemiol. 2012;47(1):87\u201395.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"2","key":"3949_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0165-1781(88)90053-4","volume":"25","author":"JW Stewart","year":"1988","unstructured":"Stewart JW, Quitkin FM, McGrath PJ, Rabkin JG, Markowitz JS, Tricamo E, et al. Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment. Psychiatry Res. 1988;25(2):213\u201322.","journal-title":"Psychiatry Res"},{"key":"3949_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/1472-6963-13-217","volume":"13","author":"C Bouwmans","year":"2013","unstructured":"Bouwmans C, De Jong K, Timman R, Zijlstra-Vlasveld M, Van der Feltz-Cornelis C, Tan Swan S, et al. Feasibility, reliability and validity of a questionnaire on healthcare consumption and productivity loss in patients with a psychiatric disorder (TiC-P). BMC Health Serv Res. 2013;13:217.","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"3949_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jpsychores.2011.05.005","volume":"71","author":"MJ Heins","year":"2011","unstructured":"Heins MJ, Knoop H, Lobbestael J, Bleijenberg G. Childhood maltreatment and the response to cognitive behavior therapy for chronic fatigue syndrome. J Psychosom Res. 2011;71(6):404\u201310.","journal-title":"J Psychosom Res"},{"issue":"6","key":"3949_CR27","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","volume":"60","author":"E Broadbent","year":"2006","unstructured":"Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631\u20137.","journal-title":"J Psychosom Res"},{"issue":"5","key":"3949_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jpsychores.2006.04.018","volume":"61","author":"TN Skerrett","year":"2006","unstructured":"Skerrett TN, Moss-Morris R. Fatigue and social impairment in multiple sclerosis: the role of patients' cognitive and behavioral responses to their symptoms. J Psychosom Res. 2006;61(5):587\u201393.","journal-title":"J Psychosom Res"},{"issue":"6","key":"3949_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"3949_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","volume":"7","author":"MJL Sullivan","year":"1995","unstructured":"Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524\u201332.","journal-title":"Psychol Assess"},{"key":"3949_CR31","volume-title":"Self-efficacy and chronic pain","author":"MK Nicholas","year":"1989","unstructured":"Nicholas MK. Self-efficacy and chronic pain. St Andrews: Annual Conference of the British Psychological Society; 1989."},{"issue":"8","key":"3949_CR32","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"key":"3949_CR33","doi-asserted-by":"crossref","unstructured":"Koetsveld J, Kolyasnikova NM, Wagemakers A, Stukolova OA, Hoornstra D, Sarksyan DS, et al. Serodiagnosis of Borrelia miyamotoi disease by measuring antibodies against GlpQ and variable major proteins. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2018.","DOI":"10.1016\/j.cmi.2018.03.009"},{"issue":"5","key":"3949_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1056\/NEJM199707313370501","volume":"337","author":"R Dattwyler","year":"1997","unstructured":"Dattwyler R, Luft B, Kunkel M, Finkel M, Wormser G, Rush T, et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med. 1997;337(5):289\u201394.","journal-title":"N Engl J Med"},{"issue":"13","key":"3949_CR35","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa1505425","volume":"374","author":"A Berende","year":"2016","unstructured":"Berende A, ter Hofstede HJ, Vos FJ, van Middendorp H, Vogelaar ML, Tromp M, et al. Randomized trial of longer-term therapy for symptoms attributed to Lyme disease. N Engl J Med. 2016;374(13):1209\u201320.","journal-title":"N Engl J Med"},{"issue":"5","key":"3949_CR36","first-page":"489","volume":"99","author":"D Cameron","year":"2008","unstructured":"Cameron D. Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial. Minerva Med. 2008;99(5):489\u201396.","journal-title":"Minerva Med"},{"issue":"2","key":"3949_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJM200107123450202","volume":"345","author":"MS Klempner","year":"2001","unstructured":"Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345(2):85\u201392.","journal-title":"N Engl J Med"},{"issue":"12","key":"3949_CR38","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","volume":"60","author":"LB Krupp","year":"2003","unstructured":"Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, Ahnn S, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003;60(12):1923\u201330.","journal-title":"Neurology."},{"issue":"7","key":"3949_CR39","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1089\/vbz.2010.0018","volume":"11","author":"D Stupica","year":"2011","unstructured":"Stupica D, Lusa L, Cerar T, Ruzic-Sabljic E, Strle F. Comparison of post-Lyme Borreliosis symptoms in erythema migrans patients with positive and negative Borrelia burgdorferi sensu lato skin culture. Vector borne and zoonotic diseases. 2011;11(7):883\u20139.","journal-title":"Vector borne and zoonotic diseases"},{"issue":"1","key":"3949_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.7326\/0003-4819-130-1-199901050-00006","volume":"130","author":"F Strle","year":"1999","unstructured":"Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York state and by Borrelia afzelii in Slovenia. Ann Intern Med. 1999;130(1):32\u20136.","journal-title":"Ann Intern Med"},{"issue":"10","key":"3949_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005042","volume":"10","author":"S Jahfari","year":"2016","unstructured":"Jahfari S, Hofhuis A, Fonville M, van der Giessen J, van Pelt W, Sprong H. Molecular detection of tick-borne pathogens in humans with tick bites and erythema Migrans, in the Netherlands. PLoS Negl Trop Dis. 2016;10(10):e0005042.","journal-title":"PLoS Negl Trop Dis"},{"key":"3949_CR42","volume-title":"Herremans T","author":"J Koetsveld","year":"2015","unstructured":"Koetsveld J, Tijsse-Klasen E. Herremans T. Sprong H. Serological and molecular evidence for spotted fever group Rickettsia and Borrelia burgdorferi sensu lato co-infections in The Netherlands. Ticks and tick-borne diseases: Hovius JW; 2015."},{"issue":"11","key":"3949_CR43","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.amjmed.2014.05.036","volume":"127","author":"PM Lantos","year":"2014","unstructured":"Lantos PM, Wormser GP. Chronic coinfections in patients diagnosed with chronic Lyme disease: a systematic review. Am J Med. 2014;127(11):1105\u201310.","journal-title":"Am J Med"},{"issue":"8","key":"3949_CR44","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1002\/art.38618","volume":"66","author":"D Londono","year":"2014","unstructured":"Londono D, Cadavid D, Drouin EE, Strle K, McHugh G, Aversa JM, et al. Antibodies to endothelial cell growth factor and obliterative microvascular lesions in the synovium of patients with antibiotic-refractory Lyme arthritis. Arthritis & rheumatology. 2014;66(8):2124\u201333.","journal-title":"Arthritis & rheumatology"},{"issue":"2","key":"3949_CR45","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/art.10772","volume":"48","author":"AC Steere","year":"2003","unstructured":"Steere AC, Falk B, Drouin EE, Baxter-Lowe LA, Hammer J, Nepom GT. Binding of outer surface protein a and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 2003;48(2):534\u201340.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"3949_CR46","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/art.22441","volume":"56","author":"JJ Shin","year":"2007","unstructured":"Shin JJ, Glickstein LJ, Steere AC. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory Lyme arthritis. Arthritis Rheum. 2007;56(4):1325\u201335.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3949_CR47","first-page":"930","volume":"64","author":"K Strle","year":"2017","unstructured":"Strle K, Sulka KB, Pianta A, Crowley JT, Arvikar SL, Anselmo A, et al. T-helper 17 cell cytokine responses in Lyme disease correlate with Borrelia burgdorferi antibodies during early infection and with autoantibodies late in the illness in patients with antibiotic-refractory Lyme arthritis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017;64(7):930\u20138.","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America."},{"issue":"11","key":"3949_CR48","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1128\/IAI.05242-11","volume":"79","author":"M Oosting","year":"2011","unstructured":"Oosting M, ter Hofstede H, van de Veerdonk FL, Sturm P, Kullberg BJ, van der Meer JW, et al. Role of interleukin-23 (IL-23) receptor signaling for IL-17 responses in human Lyme disease. Infect Immun. 2011;79(11):4681\u20137.","journal-title":"Infect Immun"},{"issue":"9","key":"3949_CR49","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1128\/CVI.00071-16","volume":"23","author":"JN Aucott","year":"2016","unstructured":"Aucott JN, Soloski MJ, Rebman AW, Crowder LA, Lahey LJ, Wagner CA, et al. CCL19 as a chemokine risk factor for posttreatment Lyme disease syndrome: a prospective clinical cohort study. Clinical and vaccine immunology : CVI. 2016;23(9):757\u201366.","journal-title":"Clinical and vaccine immunology : CVI"},{"issue":"3","key":"3949_CR50","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/cid\/cit735","volume":"58","author":"K Strle","year":"2014","unstructured":"Strle K, Stupica D, Drouin EE, Steere AC, Strle F. Elevated levels of IL-23 in a subset of patients with post-Lyme disease symptoms following erythema migrans. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014;58(3):372\u201380.","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America."},{"issue":"1","key":"3949_CR51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2337\/dc13-0515","volume":"37","author":"M Goedendorp","year":"2014","unstructured":"Goedendorp M, Tack C, Steggink E, Bloot L, Bazelmans E, Knoop H. Chronic fatigue in type 1 diabetes: highly prevalent but not explained by hyperglycemia or glucose variability. Diabetes Care. 2014;37(1):73\u201380.","journal-title":"Diabetes Care"},{"issue":"1","key":"3949_CR52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1017\/S0033291711000924","volume":"42","author":"H Knoop","year":"2012","unstructured":"Knoop H, van Kessel K, Moss-Morris R. Which cognitions and behaviours mediate the positive effect of cognitive behavioural therapy on fatigue in patients with multiple sclerosis? Psychol Med. 2012;42(1):205\u201313.","journal-title":"Psychol Med"},{"issue":"12","key":"3949_CR53","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/art.24314","volume":"59","author":"AL Hassett","year":"2008","unstructured":"Hassett AL, Radvanski DC, Buyske S, Savage SV, Gara M, Escobar JI, et al. Role of psychiatric comorbidity in chronic Lyme disease. Arthritis Rheum. 2008;59(12):1742\u20139.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3949_CR54","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1600-0404.2012.01690.x","volume":"127","author":"R Eikeland","year":"2013","unstructured":"Eikeland R, Mygland A, Herlofson K, Ljostad U. Risk factors for a non-favorable outcome after treated European neuroborreliosis. Acta Neurol Scand. 2013;127(3):154\u201360.","journal-title":"Acta Neurol Scand"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3949-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3949-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3949-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T19:07:43Z","timestamp":1586804863000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3949-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3949"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3949-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,15]]},"assertion":[{"value":"4 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by the medical ethics committee (METC) Noord-Holland (NL50227.094.14), and is conducted according to the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"324"}}